Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Potassium-Acetaminophen Combination for Anesthetic Success in Irreversible Pulpitis
NCT04593160Completed
- Sponsor
- Cairo University
- Start
- Mar 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in irreversible pulpitis comparing Diclofenac potassium- acetaminophen combination, Diclofenac potassium and Placebo (3 arms). Primary endpoint: Anesthetic success of inferior alveolar nerve block. Started Mar 2022; status: completed.
02
Drugs
diclofenacacetaminophen
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04593160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04593160.